Member Info for nomlungu

Not sure if you will see this due to your filter settings:

https://beta.companieshouse.gov.uk/company/11632505/filing-history

The.Crowman

I hope that you are proved correct - I hate seeing vultures feeding on the carcasses of private investors.

Odey is the main shorter - if you think that they are armchair experts you may well be mistaken.

https://shorttracker.co.uk/company/GB00B126KH97/

The shorters have done their research and seem to be confident that DEB will not survive - a bit like Carillion.

I suggest you contact their broker and register your interest in taking part in any placing - no doubt they will be impressed with your enthusiasm and be happy to help you buy at 50p.

This is looking worse and worse everyday...

This does not appear Valirx subsidiary according to the companies house documents...

4 shareholders at 25 percent each... they each bought 1 share at £1. The shares are owned by people associated with VAL.

Are they listening? #378moretogo

I feel it is coming.

As the near top ramper DegsyAlmomd posted about ANGS today 'Vonks suggests a guide of £35-£40m on the cap for each 100bopd to Angs.'

When news arrives and the herd get their set squares and chinese counting machines out they will get dizzy with the potential here, probably because their numbers are wrong.

Chris - maybe time to consider posting the list of links again - they will need the facts to get confused on.

http://pumpedordumped.com/rampchecker/rampchecktopramper.php

The December full moon is on Saturday the 22nd so I will be watching the bid on the next 2 Mondays [X-Mas eve and New Years eve].

https://reabold.com/projects/reabold-california/

I understand that VAL monitor the share bulletin boards about them [why else would you pay your public relations team?]. Maybe they will understand that they need to make a statement about this new company that seems to be owned by employees of the company but has used parts of their name and, seemingly, their GeneICE platform.

No doubt someone will comment shortly about all the blocked messages that they cannot see - oh well, I suppose if people want to live in an echo chamber they should not be surprised that the silence they find comforting might be having a negative effect on their wealth.

And to those who would like to say that they invested to find a cure for cancer - did any of you take part in any of VAL's placings?

A total of 4 shares have been issued at £1 each. 1 share each to K Nawani, S Vannikka, G Morris and A Chouhdury. Seems there is nothing to see here.

https://beta.companieshouse.gov.uk/company/11632505/filing-history

Let it not be forgotten that the Board are authorised to issue a further 378 million new shares should they wish, or need to.

Tony,

What compound are you expecting a bid for [101, 201, 301, 401 or GeneIce]?

If you are expecting a 10 bagger in 10 weeks you must have done extensive research and found a gem... What part of Valirx do you value so highly?

A story about the 'Father of Immunotherapy' - an interesting read.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1888599/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081367/

https://www.insider.co.uk/company-results-forecasts/debenhams-shares-house-fraser-lewis-13443420

Great fight for the belt tonight - the crowd disturbances in the early rounds made me think it was a ramper v deramper street brawl.

An interesting article on the NYT:

https://www.nytimes.com/2018/10/20/health/breast-cancer-immunotherapy.html

A Cuadrilla spokesperson said the firm "was not fracking at the time the tremors were felt" - were they fracking before the seismic activity occurred?

Pity that the media tarnished UKOG with fracking when this news comes out:

https://news.sky.com/story/tremors-detected-near-lancashire-fracking-zone-11530033

This weeks private eye has an interesting article about Luke Johnson.